quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:20·1423d
SECFiling
Antares Pharma Inc. logo

SEC Form EFFECT filed by Antares Pharma Inc.

ATRS· Antares Pharma Inc.
Health Care
Original source

Companies

  • ATRS
    Antares Pharma Inc.
    Health Care

Recent analyst ratings

  • Nov 5UpdateHC Wainwright & Co.$5.00
  • Jul 16UpdateTruist Securities$7.00

Related

  • PR1088d
    Dimension Inx announces the addition of biotech industry leaders Paul K. Wotton, Ph.D., as Board Director and Chris Ehrlich as Senior Advisor
  • NEWS1416d
    Looking Into Antares Pharma's Return On Invested Capital
  • SEC1421d
    SEC Form 15-12B filed by Antares Pharma Inc.
  • SEC1423d
    SEC Form EFFECT filed by Antares Pharma Inc.
  • SEC1423d
    SEC Form EFFECT filed by Antares Pharma Inc.
  • SEC1423d
    SEC Form EFFECT filed by Antares Pharma Inc.
  • SEC1423d
    SEC Form EFFECT filed by Antares Pharma Inc.
  • SEC1423d
    SEC Form EFFECT filed by Antares Pharma Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022